A Five-Year Review of Newborn Screening for Spinal Muscular Atrophy in the State of Utah: Lessons Learned
Spinal muscular atrophy (SMA) is an autosomal recessive condition characterized by alpha motor neuron degeneration in the spinal cord anterior horn. Clinical symptoms manifest in the first weeks to months of life in the most severe cases, resulting in progressive symmetrical weakness and atrophy of...
| Published in: | International Journal of Neonatal Screening |
|---|---|
| Main Authors: | Kristen N. Wong, Melissa McIntyre, Sabina Cook, Kim Hart, Amelia Wilson, Sarah Moldt, Andreas Rohrwasser, Russell J. Butterfield |
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-07-01
|
| Subjects: | |
| Online Access: | https://www.mdpi.com/2409-515X/10/3/54 |
Similar Items
Cost analysis of newborn screening for spinal muscular atrophy using digital PCR vs. MLPA
by: Dolat Singh Shekhawat, et al.
Published: (2025-06-01)
by: Dolat Singh Shekhawat, et al.
Published: (2025-06-01)
One-Year Pilot Study Results of Newborn Screening for Spinal Muscular Atrophy in the Republic of Croatia
by: Darija Šimić, et al.
Published: (2024-07-01)
by: Darija Šimić, et al.
Published: (2024-07-01)
Landscape of Spinal Muscular Atrophy Newborn Screening in the United States: 2018–2021
by: Kshea Hale, et al.
Published: (2021-06-01)
by: Kshea Hale, et al.
Published: (2021-06-01)
Views of the General Population on Newborn Screening for Spinal Muscular Atrophy in Japan
by: Tomoko Lee, et al.
Published: (2021-08-01)
by: Tomoko Lee, et al.
Published: (2021-08-01)
Results of the Hungarian Newborn Screening Pilot Program for Spinal Muscular Atrophy
by: Krisztina Hegedűs, et al.
Published: (2025-04-01)
by: Krisztina Hegedűs, et al.
Published: (2025-04-01)
Newborn Screening for Spinal Muscular Atrophy: Variations in Practice and Early Management of Infants with Spinal Muscular Atrophy in the United States
by: Craig M. Zaidman, et al.
Published: (2024-08-01)
by: Craig M. Zaidman, et al.
Published: (2024-08-01)
Spinal Muscular Atrophy: Diagnosis, Incidence, and Newborn Screening in Japan
by: Tomokazu Kimizu, et al.
Published: (2021-07-01)
by: Tomokazu Kimizu, et al.
Published: (2021-07-01)
Very severe spinal muscular atrophy (Type 0)
by: Suleiman Al Dakhoul
Published: (2017-01-01)
by: Suleiman Al Dakhoul
Published: (2017-01-01)
Reviews of spinal muscular atrophy in Taiwan
by: Yung-Hsiu Lu, et al.
Published: (2024-12-01)
by: Yung-Hsiu Lu, et al.
Published: (2024-12-01)
Cost-Effectiveness of Newborn Screening for Spinal Muscular Atrophy in Australian Hospitals
by: Ian R. Woodcock, et al.
Published: (2025-04-01)
by: Ian R. Woodcock, et al.
Published: (2025-04-01)
Newborn Screening Program for Spinal Muscular Atrophy in the Campania Region (Italy): Current Limitations and Potential Perspectives
by: Adelaide Ambrosio, et al.
Published: (2025-08-01)
by: Adelaide Ambrosio, et al.
Published: (2025-08-01)
Spinal muscular atrophy in the era of newborn screening: how the classification could change
by: Antonio Varone, et al.
Published: (2025-05-01)
by: Antonio Varone, et al.
Published: (2025-05-01)
Systematic Review of Newborn Screening Programmes for Spinal Muscular Atrophy
by: Katy Cooper, et al.
Published: (2024-07-01)
by: Katy Cooper, et al.
Published: (2024-07-01)
CDC’s Laboratory Activities to Support Newborn Screening for Spinal Muscular Atrophy
by: Francis K. Lee, et al.
Published: (2024-07-01)
by: Francis K. Lee, et al.
Published: (2024-07-01)
A cost-utility analysis of newborn screening for spinal muscular atrophy in Canada
by: Alex Pace, et al.
Published: (2025-08-01)
by: Alex Pace, et al.
Published: (2025-08-01)
Massachusetts’ Findings from Statewide Newborn Screening for Spinal Muscular Atrophy
by: Jaime E. Hale, et al.
Published: (2021-05-01)
by: Jaime E. Hale, et al.
Published: (2021-05-01)
A Voluntary Statewide Newborn Screening Pilot for Spinal Muscular Atrophy: Results from Early Check
by: Katerina S. Kucera, et al.
Published: (2021-03-01)
by: Katerina S. Kucera, et al.
Published: (2021-03-01)
Postnatal management of preterm infants with spinal muscular atrophy: experience from German newborn screening
by: Regina Trollmann, et al.
Published: (2024-09-01)
by: Regina Trollmann, et al.
Published: (2024-09-01)
Outcomes of a Pilot Newborn Screening Program for Spinal Muscular Atrophy in the Valencian Community
by: Alba Berzal-Serrano, et al.
Published: (2025-01-01)
by: Alba Berzal-Serrano, et al.
Published: (2025-01-01)
Our Journey from Individual Efforts to Nationwide Support: Implementing Newborn Screening for Spinal Muscular Atrophy in Serbia
by: Miloš Brkušanin, et al.
Published: (2024-08-01)
by: Miloš Brkušanin, et al.
Published: (2024-08-01)
Newborn Screening for Spinal Muscular Atrophy in China Using DNA Mass Spectrometry
by: Yiming Lin, et al.
Published: (2019-12-01)
by: Yiming Lin, et al.
Published: (2019-12-01)
The Birth Prevalence of Spinal Muscular Atrophy: A Population Specific Approach in Estonia
by: Siiri Sarv, et al.
Published: (2021-12-01)
by: Siiri Sarv, et al.
Published: (2021-12-01)
Rehabilitation in spinal muscular atrophy
by: Joanna Iłżecka
Published: (2021-05-01)
by: Joanna Iłżecka
Published: (2021-05-01)
Neonatal Screening for Spinal Muscular Atrophy and Severe T- and B-Cell Lymphopenias in Andalusia: A Prospective Study
by: Beatriz De Felipe, et al.
Published: (2025-01-01)
by: Beatriz De Felipe, et al.
Published: (2025-01-01)
Case report: A case of spinal muscular atrophy in a preterm infant: risks and benefits of treatment
by: Elisa Nigro, et al.
Published: (2023-09-01)
by: Elisa Nigro, et al.
Published: (2023-09-01)
Newborn screening facilitates early theranostics and improved spinal muscular atrophy outcome: five-year real-world evidence from Taiwan
by: Chen-Hua Wang, et al.
Published: (2025-04-01)
by: Chen-Hua Wang, et al.
Published: (2025-04-01)
Spinal Muscular Atrophy
by: J Gordon Millichap
Published: (1990-02-01)
by: J Gordon Millichap
Published: (1990-02-01)
Spinal Muscular Atrophy With Myoclonic Epilepsy
by: Buket ÖZKARA, et al.
Published: (2017-04-01)
by: Buket ÖZKARA, et al.
Published: (2017-04-01)
Oral risdiplam for specific therapy in adult patients with 5q spinal muscular atrophy in the Moscow region
by: Ekaterina S. Novikova
Published: (2023-09-01)
by: Ekaterina S. Novikova
Published: (2023-09-01)
Gene therapy-based strategies for spinal muscular atrophy—an Asia-Pacific perspective
by: Michelle A. Farrar, et al.
Published: (2023-11-01)
by: Michelle A. Farrar, et al.
Published: (2023-11-01)
Indirect estimation of the prevalence of spinal muscular atrophy Type I, II, and III in the United States
by: Cathy Lally, et al.
Published: (2017-11-01)
by: Cathy Lally, et al.
Published: (2017-11-01)
Establishment of a Pilot Newborn Screening Program for Spinal Muscular Atrophy in Saint Petersburg
by: Anton Kiselev, et al.
Published: (2024-01-01)
by: Anton Kiselev, et al.
Published: (2024-01-01)
Rehabilitation management for patients with spinal muscular atrophy: a review
by: Wei Song, et al.
Published: (2025-07-01)
by: Wei Song, et al.
Published: (2025-07-01)
Spinal muscular atrophy
by: D'Amico Adele, et al.
Published: (2011-11-01)
by: D'Amico Adele, et al.
Published: (2011-11-01)
Spinal Muscular Atrophy Types, Innovations in Diagnosis and Treatment
by: Hatice Tankisi, et al.
Published: (2023-12-01)
by: Hatice Tankisi, et al.
Published: (2023-12-01)
The social-economic burden of spinal muscular atrophy in Russia
by: A. S. Kolbin, et al.
Published: (2021-02-01)
by: A. S. Kolbin, et al.
Published: (2021-02-01)
Physical and Respiratory Rehabilitation in Spinal Muscular Atrophy: A Critical Narrative Review
by: Serena Cammarano, et al.
Published: (2025-04-01)
by: Serena Cammarano, et al.
Published: (2025-04-01)
Growth patterns in children with spinal muscular atrophy
by: Ramona De Amicis, et al.
Published: (2021-09-01)
by: Ramona De Amicis, et al.
Published: (2021-09-01)
Towards a Newborn Screening Common Data Model: The Utah Newborn Screening Data Model
by: David Jones, et al.
Published: (2021-10-01)
by: David Jones, et al.
Published: (2021-10-01)
Recombinant Adeno-Associated Virus Serotype 9 Gene Therapy in Spinal Muscular Atrophy
by: Katarzyna Kotulska, et al.
Published: (2021-10-01)
by: Katarzyna Kotulska, et al.
Published: (2021-10-01)
Similar Items
-
Cost analysis of newborn screening for spinal muscular atrophy using digital PCR vs. MLPA
by: Dolat Singh Shekhawat, et al.
Published: (2025-06-01) -
One-Year Pilot Study Results of Newborn Screening for Spinal Muscular Atrophy in the Republic of Croatia
by: Darija Šimić, et al.
Published: (2024-07-01) -
Landscape of Spinal Muscular Atrophy Newborn Screening in the United States: 2018–2021
by: Kshea Hale, et al.
Published: (2021-06-01) -
Views of the General Population on Newborn Screening for Spinal Muscular Atrophy in Japan
by: Tomoko Lee, et al.
Published: (2021-08-01) -
Results of the Hungarian Newborn Screening Pilot Program for Spinal Muscular Atrophy
by: Krisztina Hegedűs, et al.
Published: (2025-04-01)
